$RDNT

Wesdorp Cornelis sold $276K of RDNT

Wesdorp Cornelis (Pres & CEO, Digital Health) sold 4,750 shares of RadNet, Inc. (RDNT) at $58.11 ($0.28M total) on 2026-06-16.

Original reporting
SEC EDGAR · Wesdorp Cornelis
Published Jun 18, 2026, 10:03 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 18, 2026, 10:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RDNT
Neutral
high confidence
Mentioned
$RDNT
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RDNTNeutralLow
01

Why it matters

This provides a concrete datapoint on CEO selling size, price, and post-transaction holdings, but it does not introduce new operational or financial guidance.

02

Market read

Useful for monitoring insider behavior, but unlikely to drive a fundamental repricing on its own.

03

What to watch

Insider sales are common and often non-informational; traders should compare with prior insider activity and whether other executives/large holders are also selling or buying around the same period.

Relevance 4/10Novelty 5/10Timing: Filed after-hours on 2026-06-18; reflects sale executed 2026-06-16.

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for RadNet, Inc. (RDNT).

Company-level read

Ticker impact

$RDNTNeutralHigh confidence
Context

RadNet CEO Wesdorp Cornelis filed a Form 4 selling 4,750 shares at $58.11 on 2026-06-16 for ~$276K.

Expected impact

Likely limited near-term impact; any effect is more sentiment/flow-related than fundamental.

Evidence & confidence

The filing is a disclosed sale with no 10b5-1 plan and no accompanying fundamental catalyst (no guidance, deal, or regulatory action).

Market effects

Minimal; this is company-specific insider activity with no sector-wide datapoint.

None indicated.

None indicated.

Counterpoint

The absence of a stated 10b5-1 plan could be misread as bearish; the sale may be for diversification/taxes rather than a view on fundamentals.

Key entities

  • RadNet, Inc.

    Subject of the Form 4 insider sale by its CEO.

  • Wesdorp Cornelis

    President & CEO, Digital Health; reported an open-market sale of RDNT shares.

Related articles

$RDNTMed

DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite

DeepHealth, a RadNet subsidiary (NASDAQ: RDNT), said it received two FDA 510(k) clearances for its Breast Suite: Breast Arterial Calcification (BAC) Assessment and prior-exam integration into ProFound Pro, to be marketed as Mammo Dx. Both are now commercially available in the U.S. DeepHealth reported BAC performance of >90% sensitivity and >88% specificity.